Enabling equitable open access to commercially funded research publications.
Level V
Where this comes from
- Record sourced from PubMed, PMID 42658833.
- Also identified by DOI 10.1371/journal.pmed.1005207.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pharmaceutical companies fund much biomedical research, yet many journals restrict open access publishing options for peer-reviewed articles reporting commercially funded research. Expanded publishing options, such as funder-neutral publishing policies, will help address this inequity.
Medical subject headings
- Biomedical Research
- Open Access Publishing
- Drug Industry
- Periodicals as Topic
- Access to Information
- Research Support as Topic
- Publishing